Validation of a novel model for the early detection of hepatocellular carcinoma
ConclusionsCompared to each biomarker alone, the combination of AFP and PIVKA-II with age and gender improved the accuracy of detecting HCC and differentiating HCC from non-malignant liver disease.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research
More News: Biochemistry | Cancer & Oncology | Carcinoma | Cirrhosis | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Study | Urology & Nephrology | Vitamin K | Vitamins